SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-045575
Filing Date
2022-02-17
Accepted
2022-02-17 17:30:41
Documents
15
Period of Report
2022-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d275483d8k.htm   iXBRL 8-K 38961
2 EX-99.1 d275483dex991.htm EX-99.1 94415
3 EX-99.2 d275483dex992.htm EX-99.2 38025
7 GRAPHIC g275483g62j16.jpg GRAPHIC 10888
  Complete submission text file 0001193125-22-045575.txt   325341

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220215.xsd EX-101.SCH 2872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220215_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220215_pre.xml EX-101.PRE 10823
9 EXTRACTED XBRL INSTANCE DOCUMENT d275483d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 22649620
SIC: 3841 Surgical & Medical Instruments & Apparatus